Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Return on Invested Capital (2018 - 2021)

Acro Biomedical has reported Return on Invested Capital over the past 4 years, most recently at 6.27% for Q3 2021.

  • Quarterly results put Return on Invested Capital at 6.27% for Q3 2021, changed N/A from a year ago — trailing twelve months through Sep 2021 was 6.27% (changed N/A YoY), and the annual figure for FY2020 was 0.13%, up 29.0%.
  • Return on Invested Capital for Q3 2021 was 6.27% at Acro Biomedical, down from 1.27% in the prior quarter.
  • Over the last five years, Return on Invested Capital for ACBM hit a ceiling of 0.37% in Q3 2018 and a floor of 6.27% in Q3 2021.
  • Median Return on Invested Capital over the past 4 years was 0.13% (2020), compared with a mean of 0.57%.
  • Biggest five-year swings in Return on Invested Capital: grew 30bps in 2020 and later crashed -113bps in 2021.
  • Acro Biomedical's Return on Invested Capital stood at 0.21% in 2018, then tumbled by -300bps to 0.42% in 2019, then surged by 71bps to 0.12% in 2020, then plummeted by -5065bps to 6.27% in 2021.
  • The last three reported values for Return on Invested Capital were 6.27% (Q3 2021), 1.27% (Q2 2021), and 0.28% (Q1 2021) per Business Quant data.